• HPCUS Policies
    • Website Terms of Use
    • HPCUS Conflict of Interest Policy
    • HPCUS Policy on Whistleblower Protection
    • HPCUS Policy on Harassment Prevention
    • HPCUS Policy on Diversity Equity and Inclusion
  • Join / Subscribe
    • Become a Subscriber
    • Become A Friend
  • Submitting A Monograph
    • Criteria for Acceptance of an Official Monograph
    • Official Monograph Review Procedure
    • Technical Information Requirements
    • HPCUS Guidelines for Homeopathic Drug Provings
    • Guidelines for Clinical Verification
    • Sample Monograph
  • Public Comment
  • Contact
  • Donate
  • Submitting a Monograph
  • Public Comment
  • Donate
Search Log In

Friends Newsletter

Home / Friends Newsletter
  • Friends Newsletter
    • 2025 – 2026
      • May / June 2026 Newsletter #5
      • May 2025 
    • 2023 – 2024
      • September 2024
      • February 2024
      • November 2023

Friends Newsletter #2 — 2/29/2024

Dear Friends,

The White Paper project has reached an important milestone.  You can view an introduction and a non-technical summary of the three papers now out for comment by logging into your Friends account and selecting “Our projects.” In the first paragraph on the page that comes up, you will see the links for 2 documents, the Introduction to the White Papers and the summaries of the three papers.  The introduction should be read first.

These three papers are the first step in the Convention’s response to the challenges of quality manufacturing of homeopathic drugs in the United States.  They provide manufacturers with a rational, achievable, and science-based path toward compliance with FDA’s quality guidelines.  This and other aspects of the White Papers are explained in the Introduction.

The White Papers can be accessed by links in each of the two files made available to you in the Friends section.  Everyone is willing to comment on the papers themselves.  If you have questions or comments, please feel free to contact me.

With great appreciation for your participation,

William Shevin MD, DHt. (retired) President, HPCUS

2023 - 2024

HPUS

  • Legal Status and Role
  • Contact
  • Donate
  • Become a Subscriber
  • Become A Friend
  • Login

Submitting a Monograph

  • Criteria for Eligibility for Inclusion of Drugs in the HPUS
  • Official HPCUS Monograph Review Procedure
  • Guidelines to Technical Information Submission Requirements
  • HPCUS Proving Guidelines
  • HPCUS Clinical Verification Guidelines
  • Sample Monograph

HPUS (Subscriber Only Info)

  • List of Official Monographs
  • Table of Lowest Permissible Attenuations and Class of Manufacture
  • Explanation of the Attenuation Levels recognized by the HPCUS
  • Guidelines for Manufacturing Homeopathic Medicines
  • Homeopathic Good Manufacturing Practices
  • HPUS Labeling Guidelines
  • Homeopathic Drug Stability Guidelines
  • Standards and Controls – Reagents
  • Position Statements
  • HPUS Update Notifications

About

  • Publication History
  • Website Terms of Use Policy
  • Conflict of interest statement
  • Whistleblower Protection
  • Harassment Prevention
  • Diversity Equity and Inclusion Statement 

Free Update Notification Emails

Sign up to receive free email notifications of updates to the HPUS. Your information will not be shared with others and notifications will be kept to an absolute minimum (average eight times per year).

Click here to sign up

© 2026, The Homœopathic Pharmacopœia of the United States. All Rights Reserved.

  • Terms of Use Policy
  • Privacy Policy